MarketInOut Stock Screener Log In | Sign Up
 

Pangaea Oncology S.A.

BME • Healthcare • Diagnostics & Research • Quote as of 10/21/2026
Pangaea Oncology S.A. stock price and volume chart

Company Profile

IndustryDiagnostics & Research
SectorHealthcare
ExchangeBME
Market Capitalization51.36 mln
Float7.22 mln

Piotroski F-Score

1 / 9
Very weak

Beneish M-Score

-2.55
Likely reliable

Relative Strength

13 / 100
Significantly lagging

Debt / Equity

0.27
Very low leverage

Pre-Tax Margin

-28%
Deeply loss-making

ROE

-16.93
Negative

Business Description

Founded in Barcelona in 2006, Pangaea Oncology S.A. helps cancer patients across Spain and the wider European Union by offering a broad set of specialized medical services. The company runs advanced laboratory tests to study tumors at a genetic level, supports clinical trials, and develops tools to help doctors choose the most effective treatments for individual patients. It also works to identify new biological markers that can improve how cancer is diagnosed and treated.

Key Fundamentals

EPS-0.11
ROE-16.93
RPS0.40
ROIC-12.85
ROA-11.47
Interest Cover-12.20
EBITDA, mln-0.95
EV / EBITDA-58.00
EV / EBIT-14.73
Revenue, mln14.52
EV / Revenue3.78

Quote Details

Last 1.47
Change 0 (0%)
Open 1.47
Volume 30,504
Turnover 44,841
Average Volume 2,363.52

Financial Ratios

Pre-Tax Profit Margin-28
Leverage Ratio1.51
Current Ratio1.78
Price / Book2.41
Price / Tangible Book7.94
Debt / Equity0.27
Price / Sales3.44

Financial Strength

Altman Z-Score2.72
Piotroski F-Score 1 / 9
Beneish M-Score-2.55

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 2.8% 83 / 100   
1 Month -5.77% 37 / 100   
2 Months -12.5% 22 / 100   
6 Months -14.53% 28 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog